Gilead Sciences Inc (GILD)
NASDAQ · Healthcare · Drug Manufacturers - General
Gilead Sciences Inc is a Healthcare company with a market capitalization of $171.48B and a dividend yield of 1.74%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q2 2026 | August 3, 2026 | $-6.75 | $-7.07 | +4.5% |
| Q1 2026 | May 7, 2026 | $2.03 | $1.91 | +6.3% |
| Q4 2025 | February 10, 2026 | $1.86 | $1.81 | +2.8% |
| Q3 2025 | October 30, 2025 | $2.47 | $2.14 | +15.4% |
| Q2 2025 | August 7, 2025 | $2.01 | $1.95 | +3.1% |
| Q1 2025 | April 24, 2025 | $1.81 | $1.78 | +1.7% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 25,261,911 | 2.01% | 3.7 | -0.9% |
| June 30, 2026 | 25,484,358 | 2.03% | 2.7 | +6.8% |
| June 15, 2026 | 23,861,932 | 1.90% | 2.7 | -7.2% |
| May 29, 2026 | 25,725,417 | 2.05% | 3.8 | +11.2% |
| May 15, 2026 | 23,135,379 | 1.84% | 3.6 | +0.4% |
| April 30, 2026 | 23,051,059 | 1.84% | 4.1 | +1.3% |
| April 15, 2026 | 22,751,109 | 1.82% | 4.7 | +5.7% |
| March 31, 2026 | 21,524,970 | 1.72% | 3.2 | +7.7% |
Other Drug Manufacturers - General Stocks
Frequently Asked Questions
What is Gilead Sciences Inc's market cap?
As of August 13, 2026, Gilead Sciences Inc (GILD) has a market capitalization of $171.48B.
Does Gilead Sciences Inc pay a dividend?
Yes — Gilead Sciences Inc pays a dividend yielding 1.74%, an annual payout of $3.22 per share.
What sector is GILD in?
Gilead Sciences Inc is in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What is Gilead Sciences Inc's short interest?
As of the July 15, 2026 FINRA settlement, 25,261,911 GILD shares were sold short, or 2.01% of shares outstanding. Days to cover: 3.7. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Gilead Sciences Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Gilead Sciences Inc reported revenue of $29.44B and net income of $8.51B.
Ask your own questions about GILD
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.